Navigation Links
Legal ruling may put endangered species in danger

Wilson, Pellegrino Research Professor in Entomology, Harvard University; Gus Speth, dean of Yale University's School of Forestry and Environmental Studies; Stuart Pimm, the Doris Duke Professor of Conservation Biology at Duke University; Michael Soulé, professor emeritus of environmental studies at the University of California, Santa Cruz; Reed Noss, president of the North American Section of the Society for Conservation Biology; and Phil Hedrick, Ullman Professor of Biology at Arizona State University.

Leading environmental philosophers who signed the letter include Holmes Rolston, III, University Distinguished Professor of Environmental Ethics at Colorado State University; J. Baird Callicott, Regents' Distinguished Professor of Environmental Ethics at the University of North Texas; and Bryan Norton, professor of environmental ethics and policy at Georgia Institute of Technology.

"The Solicitor's ruling presents ecological, philosophical and logical problems," explained Nelson, "The ESA is an act that codifies an ethic which asserts that species possess intrinsic value. This recent ruling attempts to undo a moral commitment made by the American people in 1973."

"Congressional intent about the Act is clear," said Vucetich, who recently co-authored a scholarly article with Nelson on the meaning of the words "endangered" and "recovery" in the Endangered Species Act. Their paper was published in the October 5, 2006 issue of the peer-reviewed journal, Conservation Biology. "The Act is intended to allow species to be restored throughout a large portion of their former or historic range. We object to the Solicitor's ruling because it waters down the Act."

Vucetich, Nelson, and the other experts who signed the letter are urging Secretary Kempthorne to "consult with the nation's leading environmental scholars before defining terms such as endangered species."


'"/>

Source:Michigan Technological University


Page: 1 2

Related biology news :

1. Leading scientists rank endangered dolphins, porpoises most in need of immediate action
2. Time and money make a difference in endangered species recovery
3. Costly breeding programs for endangered species pay off
4. Removing egg from nest may help save endangered whooping crane
5. Cattle grazing may help rather than hurt endangered species
6. Envisat radar surveillance protects endangered prehistoric fish
7. Overfishing may drive endangered seabird to rely upon lower quality food
8. Seal rookeries could provide a reliable food source for endangered California condors, study finds
9. Rare Tibetan antelope listed as endangered
10. Protecting endangered species helps reduce poverty
11. Scientist warns of threat to last stronghold of endangered turtle

Post Your Comments:
(Date:11/4/2009)... , St. Louis, MO, November 4, 2009 Childhood obe...portions. With more than one fourth of advertising...oods and beverages and continuing questions about ...he November/December issue of the Journal of Nutr...vertising aimed at children might be a large contr...
(Date:11/4/2009)... , MADISON, N.J., Oct. 20 /PRNewswire-FirstCa...), the world,s leading provider of diagnostic test...the third quarter ended September 30, 2009, income...or $1.02 per diluted share, from $160 million, or ...2008. In 2008, third quarter results were reduced ...
(Date:11/4/2009)... , WALL, N.J., Oct. 26 /PRNewswire-FirstCall/...d: BKYI), a leader in finger-based biometric ident... identity solutions at the AABB TXPO conference be... October 25-27 2009. BIO-key will provide hands-on...entification technology in booth #424. Also, at 5 ...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17BIO-key(R) International Exhibiting at AABB TXPO 2Allied World U S Announces Strategic Response 28SM 29 Complimentary Service Added to General Liability Lead Umbrella Product 48376 1Allied World U S Announces Strategic Response 28SM 29 Complimentary Service Added to General Liability Lead Umbrella Product 48376 2Allied World U S Announces Strategic Response 28SM 29 Complimentary Service Added to General Liability Lead Umbrella Product 48376 3Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection 48373 1Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection 48373 2The secret of a snakes slither 8777 1
... Pretreatment with double-dose anticlotting medica...n (PCI) cuts the combined risk of heart attack and...ted at the 30th Annual Scientific Sessions of the ...ntions (SCAI), May 9?2, 2007, in Orlando, FL. , R... mg of clopidogrel before stenting, rather than th...
... Pigs carry hepatitis E virus (HEV), which they ca...ublished in Online Open Access journal BMC Veterin...o minimise the risk of human infection. The scenar...nfection rate in pigs drops. At low infection rate...s on HEV to humans at slaughter. , Kunio Satou and...
... Researchers at the University of Illinois at Chic...earch how an enzyme acts on the heart,s pacemaker ...-flight" reaction to adrenaline. , A single cell ...ing the pace of the beating heart, triggering its ...ll -- the pacemaker cell -- beats faster or slower...
Other Biology News:High-dose anticlotting drug cuts heart attack, death risk in half 2Slowing the racing heart 2
(Date:11/6/2009)...swire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ON...day announced updated results from a Phase II stud...omas metastatic to the lung in a poster presentati...ociety Meeting held in Miami Beach, Florida, from ...tled "A Phase II Study of Intravenous REOLYSIN (Wi...
(Date:11/6/2009)...e agenda for Arrowhead’s 2010 Personalized M...ake place on February 22-24, 2010 in Philadelphia,...we will highlight key issues in forming partnershi...eriences. , Minneapolis, ...whead’s 2010 Personalized Medicine Partners...
(Date:11/5/2009).... 5 GenVec, Inc. (Nasdaq...r the third quarter ended September 30, 2009. GenV...share) for the three months ended September 30, 20...er share) in the comparable quarter of 2008. For t...net loss was $14.1 million ($0.15 per share), comp...
(Date:11/5/2009)... 5 DSM Pharmaceutical Products tod...ance with Galenix, Saint Jean D,Illac, France, whe...facturing partner for Galenix commercial products ...aborate on business development opportunities co-m... on the strength of Galenix in drug product develo...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
... is the World,s First Fully-Automated Random Acces...ay at AACC Meeting, SUNNYVALE, Calif., July 29 C...rt(R) Infinity-48 high-throughput system,at the 20...ual Meeting in,Washington, D.C. The newest additio...ostic testing systems delivers the world,s first a...
...LEY, Mass., July 29 Xceed,Molecular, a pioneer in...ne-expression analysis systems, will launch its ne... for use with the company,s Ziplex automated,gene-... Clinical Lab Expo,(booth 2155). The Clinical Lab ...n Center in Washington, DC., "With our expanding ...
...ate and local officials have taken steps to begin ...rials, a major step for a cutting-edge technology ...ment. , On July 28, the Cambridge (Mass.) Public... that Cambridge take several steps to gain a bette...chnology-related activities now underway within th...
Other Biology Technology:Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 2Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 3Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 4Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155 2Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155 3Local officials move toward monitoring nanotechnologies 2Local officials move toward monitoring nanotechnologies 3
Rat CXCL7 (NAP-2) ELISA development Kit, DuoSet Economy Pack from R&D Systems
X-Gal from GE Healthcare, formerly Amersham Biosciences
Rat Fas, Unconjugated from R&D Systems
RABBIT (NORMAL) COMPLEMENT from AbD Serotec
Biology Products: